logo

Access Infinity Joins SME Climate Hub in Commitment to Climate Action

March 15th, 2024

LONDON, UK — 15th March 2024, Access Infinity, an award-winning market access consultancy and digital solutions firm, is pleased to announce its membership in the SME Climate Hub, a global initiative dedicated to empowering small to medium-sized enterprises to take tangible steps towards climate action and resilience building.

Recognising that climate change poses a threat to the economy, nature and society at large, Access Infinity commits to take action immediately in order to:

  • Halve their greenhouse gas emissions before 2030
  • Achieve net zero emissions before 2050
  • Disclose their progress on a yearly basis

In doing so, they are proud to be recognised by the United Nations Race to Zero campaign, and join governments, businesses, cities, regions, and universities around the world that share the same mission. 

Access Infinity’s Partner, Nick Proctor shares his enthusiasm about the company’s new direction: 

"This is an exciting step in Access Infinity's growth. We have made this commitment in recognition that our clients need more than just the project excellence they are used to, they need an environmentally responsible partner too. We are delighted to make this change for our clients, communities and the world we live in."
Nick Proctor
Partner

Through its membership in the SME Climate Hub, Access Infinity seeks to collaborate with like-minded businesses, share best practices, and drive positive change within its industry and beyond.

For more information about Access Infinity and its commitment to climate action, please visit: SME Climate Hub.

About Access Infinity

Access Infinity exists to help pharma companies overcome market access challenges. Founded in 2014, the company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Library to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.

With offices in London, Hyderabad and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s leading companies such as Astra Zeneca, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”. 

 
For more information, press only:
Tel: +44 (0)20 4583 5450